Cargando…
An RNA-targeted therapy for dystrophic epidermolysis bullosa
Functional impairment or complete loss of type VII collagen, caused by mutations within COL7A1, lead to the severe recessive form of the skin blistering disease dystrophic epidermolysis bullosa (RDEB). Here, we successfully demonstrate RNA trans-splicing as an auspicious repair option for mutations...
Autores principales: | Peking, Patricia, Koller, Ulrich, Duarte, Blanca, Murillas, Rodolfo, Wolf, Susanne, Maetzig, Tobias, Rothe, Michael, Kocher, Thomas, García, Marta, Brachtl, Gabriele, Schambach, Axel, Larcher, Fernando, Reichelt, Julia, Bauer, Johann W., Murauer, Eva M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737646/ https://www.ncbi.nlm.nih.gov/pubmed/28973459 http://dx.doi.org/10.1093/nar/gkx669 |
Ejemplares similares
-
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017) -
Structural basis for HflXr-mediated antibiotic resistance in Listeria monocytogenes
por: Koller, Timm O, et al.
Publicado: (2022) -
Discovery of new type I toxin–antitoxin systems adjacent to CRISPR arrays in Clostridium difficile
por: Maikova, Anna, et al.
Publicado: (2018) -
The dsRBP Staufen2 governs RNP assembly of neuronal Argonaute proteins
por: Ehses, Janina, et al.
Publicado: (2022) -
A mechanism underlying position-specific regulation of alternative splicing
por: Hamid, Fursham M., et al.
Publicado: (2017)